155 related articles for article (PubMed ID: 10414734)
1. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome.
Bogers HA; Sedelaar JP; Beerlage HP; de la Rosette JJ; Debruyne FM; Wijkstra H; Aarnink RG
Urology; 1999 Jul; 54(1):97-104. PubMed ID: 10414734
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer.
Gao Y; Liao XH; Lu L; Wang L; Ma Y; Qin HZ; Yan X; Guo P
Clin Radiol; 2016 Mar; 71(3):258-64. PubMed ID: 26738964
[TBL] [Abstract][Full Text] [Related]
3. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer.
Unal D; Sedelaar JP; Aarnink RG; van Leenders GJ; Wijkstra H; Debruyne FM; de la Rosette JJ
BJU Int; 2000 Jul; 86(1):58-64. PubMed ID: 10886084
[TBL] [Abstract][Full Text] [Related]
5. The utility of transrectal real-time elastography in the diagnosis of prostate cancer.
Kamoi K; Okihara K; Ochiai A; Ukimura O; Mizutani Y; Kawauchi A; Miki T
Ultrasound Med Biol; 2008 Jul; 34(7):1025-32. PubMed ID: 18255215
[TBL] [Abstract][Full Text] [Related]
6. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
[TBL] [Abstract][Full Text] [Related]
7. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
[TBL] [Abstract][Full Text] [Related]
8. Value of contrast-enhanced sonographic micro flow imaging for prostate cancer detection with t-PSA level of 4-10 ng/mL.
Guo YF; Li FH; Xie SW; Xia JG; Fang H; Li HL
Eur J Radiol; 2012 Nov; 81(11):3067-71. PubMed ID: 22647421
[TBL] [Abstract][Full Text] [Related]
9. Transrectal ultrasound microbubble contrast angiography of the prostate.
Ragde H; Kenny GM; Murphy GP; Landin K
Prostate; 1997 Sep; 32(4):279-83. PubMed ID: 9288187
[TBL] [Abstract][Full Text] [Related]
10. Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies.
Taymoorian K; Thomas A; Slowinski T; Khiabanchian M; Stephan C; Lein M; Deger S; Lenk S; Loening SA; Fischer T
Anticancer Res; 2007; 27(6C):4315-20. PubMed ID: 18214038
[TBL] [Abstract][Full Text] [Related]
11. Does the adjunct of ecographic contrast medium Levovist improve the detection rate of prostate cancer?
Pepe P; Patanè D; Panella P; Aragona F
Prostate Cancer Prostatic Dis; 2003; 6(2):159-62. PubMed ID: 12806376
[TBL] [Abstract][Full Text] [Related]
12. Transrectal doppler ultrasound during prostate biopsy: clinical utility and limitations.
Ezquer A; Ortega Hrescak MC; Sanagua C; Roggia-Rebullida P; López R; Cenice F; Veglia FH; Veglia F; Fernández A
Actas Urol Esp; 2015; 39(1):13-9. PubMed ID: 24630842
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of power doppler and ultrasound contrast agents in early imaging-based diagnosis of organ-confined prostate cancer: Is it possible to spare cores with contrast-guided biopsy?
Delgado Oliva F; Arlandis Guzman S; Bonillo García M; Broseta Rico E; Boronat Tormo F
Eur J Radiol; 2016 Oct; 85(10):1778-1785. PubMed ID: 27666616
[TBL] [Abstract][Full Text] [Related]
15. Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasound and systematic random biopsies to detect prostate cancer.
Morelli G; Pagni R; Mariani C; Minervini R; Morelli A; Gori F; Ferdeghini EM; Paterni M; Mauro E; Guidi E; Armillotta N; Canale D; Vitti P; Caramella D; Minervini A
J Urol; 2011 Jun; 185(6):2126-31. PubMed ID: 21496853
[TBL] [Abstract][Full Text] [Related]
16. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score.
Mitterberger M; Pinggera GM; Horninger W; Bartsch G; Strasser H; Schäfer G; Brunner A; Halpern EJ; Gradl J; Pallwein L; Frauscher F
J Urol; 2007 Aug; 178(2):464-8; discussion 468. PubMed ID: 17561137
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: comparison with conventional ultrasonography.
Xie SW; Li HL; Du J; Xia JG; Guo YF; Xin M; Li FH
BJU Int; 2012 Jun; 109(11):1620-6. PubMed ID: 21939490
[TBL] [Abstract][Full Text] [Related]
18. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer.
Sedelaar JP; Aarnink RG; van Leenders GJ; Beerlage HP; Debruyne FM; Wijkstra H; de La Rosette JJ
Eur Urol; 2000 May; 37(5):559-68. PubMed ID: 10765094
[TBL] [Abstract][Full Text] [Related]
19. Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy--comparison with MRI.
Drudi FM; Giovagnorio F; Carbone A; Ricci P; Petta S; Cantisani V; Ferrari FS; Marchetti F; Passariello R
Ultraschall Med; 2006 Apr; 27(2):146-51. PubMed ID: 16602039
[TBL] [Abstract][Full Text] [Related]
20. Power Doppler ultrasonography-directed prostate biopsy in men with elevated serum PSA levels: an evaluation of the clinical utility and limitations.
Takahashi S; Yamada Y; Homma Y; Horie S; Hosaka Y; Kitamura T
Urology; 2002 Aug; 60(2):248-52. PubMed ID: 12137821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
